Dr. Todd M. Sanger is currently a Research Fellow in Advanced Analytics where he leads the Business Analytics group supporting Sales and Marketing at Lilly. From 2010 to 2012 he was a member of Global Statistical Sciences (GSS) supporting the Men’s Health and Diabetes areas. From 2002 to 2009, Dr. Sanger was the Senior Director of Global Statistical Sciences. He was responsible for all areas of statistics within Global Brand Development as well as for Global Statistical Operations at Lilly.
From 1999-2002, Dr. Sanger was the manager of operations for the Symbyax Product Team where he was responsible for all aspects of the development and registration of the combination product. Prior to that, he was the principal statistician for the Zyprexa Product Team leading the team through numerous submissions and approvals for the treatment of psychosis and bipolar disorder.
Dr. Sanger is an author of over 25 manuscripts and 100 presentations, many in the field of psychiatry. His current interests include data mining, marketing analytics, linear models, causality analysis, and statistical computing.
Also, Dr. Sanger is a member of the American Statistical Association, including the Biopharmaceutical Section, Marketing Section, and the local Central Indiana Chapter.